Malki, M. M. A., Chen, Y., Jain, T., Keyzner, A., Solh, M., Popat, U., Donato, M., Pineiro, L., Fernandez, H., Gill, S., Snow, A., Uberti, J., White, T., Wang, Y., Nguyen, C., Louis, C., Chattopadhyay, S., Matzko, M., Reshef, R. (2025). TSC-101 eliminates recipient hematopoietic cells and demonstrates potential for improved relapse-free survival in patients with AML, ALL, or MDS undergoing allogeneic HCT: Updated results from the Phase 1 (ALLOHA) trial. Blood. https://doi.org/10.1182/blood-2025-2391